COVID-19

A standard test that assesses blood cells can identify which patients who are admitted to the hospital with the novel coronavirus (COVID-19) face a

Using demographic and clinical data gathered from seven weeks of novel coronavirus  (COVID-19) patient care across five hospitals, Johns Hopkins

Children and adults exhibit distinct immune system responses to infection by the virus that causes the novel coronavirus (COVID-19), which may

When the novel coronavirus (COVID-19) pandemic is slowing, low-cost, recurring screening of asymptomatic people, at an expense of approximately $3 or

Receiving the influenza vaccine does not increase a person's risk for contracting the novel coronavirus (COVID-19) or worsen associated morbidity or

A team of researchers from the University of Connecticut validated the clinical feasibility of the All-In-One-Dual CRISPR-Cas12a (AIOD-CRISPR) method

A new test for the novel coronavirus (COVID-19) known as STOPCovid detected 93 percent of the positive cases as determined by the standard polymerase